SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY

Antonia Zhu,Hilary Bews,David Cheung,Raghu S. Nagalingam,Ishika Mittal,Vineet Goyal,Chantal Y. Asselin,Iain D.C. Kirkpatrick,Michael P. Czubryt,Davinder S. Jassal

SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY

2019

Antonia Zhu
Hilary Bews
David Cheung
Raghu S. Nagalingam
Ishika Mittal
Vineet Goyal
Chantal Y. Asselin
Iain D.C. Kirkpatrick
Michael P. Czubryt
Davinder S. Jassal

Interstitial fibrosis is a histopathological hallmark of hypertrophic cardiomyopathy (HCM). Although extracellular matrix (ECM) biomarkers, including matrix metalloproteinases, are overexpressed in...

Keywords:

Internal medicine
Diabetes mellitus
Hypertrophic cardiomyopathy
Cardiology
Scleraxis
Fibrosis
Medicine
myocardial fibrosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations